{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:04:19Z","timestamp":1761858259493,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.medcli.2022.02.013","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"page":"569-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease"],"prefix":"10.1016","volume":"159","author":[{"given":"Haitham M.H.","family":"Qutob","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramadan A.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Bali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz","family":"Osailan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumana","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamilah","family":"Alyami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raed","family":"Alserihi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama A.","family":"Shaikhomar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2022.02.013_bib0290","first-page":"1199","article-title":"Early transmission dynamics in Wuhan","volume":"382","author":"Li","year":"2020","journal-title":"China, of novel coronavirus\u2013inected pneumonia. N Engl J Med."},{"key":"10.1016\/j.medcli.2022.02.013_bib0295","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res."},{"key":"10.1016\/j.medcli.2022.02.013_bib0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J Adv Res"},{"doi-asserted-by":"crossref","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395:497-506.","key":"10.1016\/j.medcli.2022.02.013_bib0165","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"10.1016\/j.medcli.2022.02.013_bib0170","series-title":"Paper presented at: Seminars in immunopathology","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","author":"Channappanavar","year":"2017"},{"key":"10.1016\/j.medcli.2022.02.013_bib0300","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.medcli.2022.02.013_bib0180","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.12998\/wjcc.v9.i20.5352","article-title":"COVID-19: considerations about immune suppression and biologicals at the time of SARS-CoV-2 pandemic","volume":"9","author":"Costanzo","year":"2021","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.medcli.2022.02.013_bib0305","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13020-021-00478-3","article-title":"Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review","volume":"16","author":"Fan","year":"2021","journal-title":"Chin Med."},{"key":"10.1016\/j.medcli.2022.02.013_bib0190","first-page":"1775","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","volume":"323","author":"Onder","year":"2020","journal-title":"JAMA"},{"doi-asserted-by":"crossref","unstructured":"Petrilli CM, Jones SA, Yang J, Rajagopalan H, O\u2019Donnell L, Chernyak Y, et al. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. MedRxiv. 2020.04.08.20057794.","key":"10.1016\/j.medcli.2022.02.013_bib0310","DOI":"10.1101\/2020.04.08.20057794"},{"key":"10.1016\/j.medcli.2022.02.013_bib0315","first-page":"475","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan","volume":"8","author":"Yang","year":"2020","journal-title":"China: a single-centered, retrospective, observational study. Lancet Respir Med."},{"key":"10.1016\/j.medcli.2022.02.013_bib0320","first-page":"1054","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan","volume":"395","author":"Zhou","year":"2020","journal-title":"China: a retrospective cohort study. Lancet."},{"key":"10.1016\/j.medcli.2022.02.013_bib0325","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan","volume":"75","author":"Zhang","year":"2020","journal-title":"China. Allergy."},{"key":"10.1016\/j.medcli.2022.02.013_bib0330","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jcv.2004.07.006","article-title":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients","volume":"31","author":"Lee","year":"2004","journal-title":"J Clin Virol."},{"key":"10.1016\/j.medcli.2022.02.013_bib0335","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2020.17022","article-title":"Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial","volume":"324","author":"Angus","year":"2020","journal-title":"Jama."},{"key":"10.1016\/j.medcli.2022.02.013_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02339-3","article-title":"Why tocilizumab could be an effective treatment for severe COVID-19?","volume":"18","author":"Fu","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.medcli.2022.02.013_bib0340","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proceedings of the National Academy of Sciences."},{"key":"10.1016\/j.medcli.2022.02.013_bib0345","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40121-020-00373-8","article-title":"Combination of tocilizumab and steroids to improve mortality in patients with severe COVID-19 infection: a Spanish, multicenter, cohort study","volume":"10","author":"Ruiz-Antor\u00e1n","year":"2021","journal-title":"Infect Dis Ther."},{"year":"2020","author":"World Health Organization","series-title":"Clinical management of COVID-19: interim guidance, 27 May 2020","key":"10.1016\/j.medcli.2022.02.013_bib0240"},{"key":"10.1016\/j.medcli.2022.02.013_bib0245","doi-asserted-by":"crossref","first-page":"102568","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia","volume":"19","author":"Toniati","year":"2020","journal-title":"Italy Autoimmun Rev"},{"issue":"Suppl 2","key":"10.1016\/j.medcli.2022.02.013_bib0350","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.arbres.2021.02.021","article-title":"Characteristics and Risk Factors Associated With Mortality in a Multicenter Spanish Cohort of Patients With COVID-19 Pneumonia","volume":"57","author":"Mu\u00f1oz-Rodr\u00edguez","year":"2021","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.medcli.2022.02.013_bib0255","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/1744666X.2019.1629904","article-title":"Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome","volume":"15","author":"Kotch","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.medcli.2022.02.013_bib0260","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.medcli.2022.02.013_bib0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237831","article-title":"Tocilizumab and steroid treatment in patients with COVID-19 pneumonia","volume":"15","author":"Mikulska","year":"2020","journal-title":"PLoS One."},{"key":"10.1016\/j.medcli.2022.02.013_bib0270","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","article-title":"Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease","volume":"112","author":"Nishimoto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2022.02.013_bib0360","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/jmv.25767","article-title":"Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19","volume":"92","author":"Qu","year":"2020","journal-title":"J Med Virol."},{"key":"10.1016\/j.medcli.2022.02.013_bib0365","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/jama.2020.16761","article-title":"Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial","volume":"324","author":"Dequin","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.medcli.2022.02.013_bib0285","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.2020.8115","article-title":"Randomized clinical trials and COVID-19: managing expectations","volume":"323","author":"Bauchner","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2022.02.013_bib0370","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia","volume":"19","author":"Toniati","year":"2020","journal-title":"Italy. Autoimmun Rev."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775322001403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775322001403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:55:41Z","timestamp":1758419741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775322001403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0025775322001403"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2022.02.013","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2022.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}